Johns Hopkins University clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
39 trials changed in the last 30 days: 1 stopped, 18 with notable changes, 20 with minor changes only.
- Notable: SHIELD · Sight and Hearing Investigation Into Effects on Delirium Results posted: Nov 18, 2026
- Notable: Treating Traumatic Brain Injury With Transcranial Direct Current Stimulation Start date pushed from Jan 15, 2027 to Mar 15, 2027
- Notable: STURDY · Estrogen Supplementation and Bone Health · CF Primary completion pushed from Jan 2027 to Jan 2028
- Minor: Herbal Supplement (Biocidin REMOVE) for Bacterial Overgrowth in Irritable Bowel Syndrome Trial status changed: Enrolling by Invitation → Recruiting
- Notable: Noninvasive Trigeminal Nerve Stimulation During Exercise Recruitment opened
- Minor: High Intensity Dysphagia Rehab for Acute Ischemic Stroke Patients Trial status changed: Enrolling by Invitation → Completed
- Minor: H2H · Community Health Worker-Led Intervention to Increase Cardiac Rehabilitation Participation Primary completion pushed from Nov 1, 2026 to Dec 1, 2026
- Minor: ReVIVE · Rehabilitation Through Virtual Immersion & Integrated Exposure for Mild Traumatic Brain Injury (ReVIVE for mTBI) Start date pushed from Oct 2026 to Nov 2026
- Minor: Using CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care Continuum Study completion pushed from Nov 1, 2026 to Nov 1, 2027
- Minor: URBACAM-D · Cardiometabolic Disease Risk Factors in Cameroon Study completion pushed from Feb 12, 2027 to Dec 12, 2027
- Notable: LaLeLa · LalelaLung Study: Digital Stethoscope Clinical Evaluation Start date pushed from Nov 2, 2026 to Dec 7, 2026
- Minor: Cerebellar Involvement in Cognitive Sequencing Primary completion pushed from Nov 30, 2026 to Dec 30, 2026
- Notable: Cannabidiol (CBD) · ASD Primary and study completion pushed from Dec 2026 to Dec 2027
- Notable: Deep Brain Stimulation for Treatment-Resistant Schizophrenia Start date pushed from Nov 1, 2026 to Jan 1, 2027
- Minor: CONNECT · Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials Study completion pushed from Oct 2026 to Dec 31, 2026
- Notable: NAGIC · Oral N-acetylglucosamine in Crohn's Disease Start date pushed from Nov 1, 2026 to Jan 5, 2027
- Notable: PROTECT-ED · Prevention and Rapid Outreach for Treatment, Engagement, and Care Transition From the Emergency Department Start date pushed from Nov 1, 2026 to Dec 15, 2026
- Minor: Psilocybin-assisted Treatment for Cannabis Use Disorder Enrollment closed, study ongoing
- Minor: DASH-Life · Groceries Plus Multi-Component Lifestyle Intervention · Hypertension and Type 2 Diabetes Enrollment closed, study ongoing
- Minor: STRIVE · RSVPreF3 Vaccine in Immunocompromised Persons Primary completion pushed from Nov 2026 to Apr 2027
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-17 | NCT07940751 Screening fOR Throat Cancer | Not Yet Recruiting | |
| 2026-11-13 | NCT07934394 Cardiovascular Research Outreach Through Women's Beauty Networks | Not Yet Recruiting | |
| 2026-11-09 | NCT07923903 Research Participant Registry "Hopkins Opportunities for Participant Engagement" | Not Yet Recruiting | |
| 2026-11-05 | NCT07920081 Psilocybin for Amblyopia - Targeting Critical Periods in Humans | Phase 1/2 | Recruiting |
| 2026-11-03 | NCT07912242 Cerebellar Brain Stimulation Plus Language Therapy for People at Risk of Poor Aphasia… | Not Yet Recruiting | |
| 2026-11-02 | NCT07909161 Team-Based Shared Decision-Making Program in Hypertension Control (Healthy Heart - BP… | Not Yet Recruiting | |
| 2026-11-02 | NCT07909746 VectorCAM: A Digital Innovation to Advance Entomological Surveillance | Completed | |
| 2026-10-28 | NCT07900828 Peer-led, Mobile App Supported Linkage to Opioid Use Disorder Treatment | Not Yet Recruiting | |
| 2026-10-22 | NCT07890337 Rehabilitation Through Virtual Immersion & Integrated Exposure for Mild Traumatic Brain… | Phase 1 | Recruiting |
Active trials by phase
| Early Phase 1 | 11 | |
| Phase 1 | 34 | |
| Phase 1/2 | 8 | |
| Phase 2 | 41 | |
| Phase 2/3 | 6 | |
| Phase 3 | 11 | |
| Phase 4 | 13 |
Not charted: 264 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 48
Stroke (21) · Diabetes (20) · Heart Disease (20) · Dementia (17) · Hypertension (16) · Obesity (14) · Depression (12) · Alzheimer's Disease (9) · Heart Failure (7) · Type 2 Diabetes (6)
Get alerts when Johns Hopkins University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.